Clinical Trial Update: To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Perrigo/Pagadis product to FDA-approved product for treatment of secondarily infected traumatic skin lesions; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Secondarily Infected Traumatic Skin Lesions

Drugs mentioned

• FDA Approved Product
• Perrigo's Product

Snippet

Sponsor: Padagis LLC | Conditions: Secondarily Infected Traumatic Skin Lesions | Phase 3 | Status: COMPLETED | Results posted: 2022-11-03